Skip to content

Author

Anne-Murielle Hollinger

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Meta-analysis Open access Sep 2026

Sex, Timing, and Outcomes of Curative-Intent Immunotherapy

This systematic review and meta-analysis evaluates associations between immune checkpoint inhibitors and survival outcomes by patient sex and timing of administration among patients receiving curative treatment for solid tumors.

Anne-Murielle Hollinger, C. Gerard, V. Andreas et al. · 0 citations
Review Open access Sep 2026

Post-CDK4/6 inhibitor therapy in HR+/HER2– advanced breast cancer: expanding options and persisting uncertainties

Endocrine treatment in combination with CDK4/6 inhibitors represents the mainstay of first-line palliative treatment in HR+/HER2– breast cancer. The treatment landscape after progression on CDK4/6 inhibitors has evolved into a complex and rapidly evolving field, driven by novel endocrine and targeted agents, new combin...

Anne-Murielle Hollinger, R. Bill · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.